Found 27 results
Author [ Title(Desc)] Type Year
Filters: Author is Dally, L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
G Manyonyi, O., Jaoko, W., Wakasiaka, S., Bwayo, J., Achola, N. J., Schmidt, C., et al.. (2005). Challenges Experienced By the Clinical Team During The Conduct of HIV Vaccine Clinical Trials in Kenya. In AIDS Vaccine 2005 International Conference. presented at the 06/09/2005, Montreal, Quebec, Canada.
Karita, E., Anzala, O., Gazzard, B., Bergin, P., Nyombayire, J., Omosa, G., et al.. (2014). Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G(NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers. In HIVR4P (HIV Research for Prevention). presented at the 28/10/2014, Cape Town, South Africa. Retrieved from http://hivr4p.org/
D
Merli, M., Riggio, O., & Dally, L.. (1996). Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology, 23(5), 1041-6. presented at the 1996 May. doi:10.1002/hep.510230516
P
Peters, B., Jaoko, W., Anzala, O., Judges, L., G Manyonyi, O., Sharp, A., et al.. (2005). Phase 2A Dose and Route Study of a DNA Prime MVA Boost Vaccine Candidate. In AIDS Vaccine 2005 International Conference. presented at the 06/09/2005, Montreal, Quebec, Canada.
S
Vardas, E., Pantaleo, G., Bart, P. A., Robinson, A., Pieterse, C., Thomas, R., et al.. (2005). Safety and Immunogenicity of MVA.HIVA by 3 Different Routes. In AIDS Vaccine 2005 International Conference. presented at the 06/09/2005, Montreal, Quebec, Canada.
Van Damme, L., Niruthisard, S., Atisook, R., Boer, K., Dally, L., Laga, M., et al.. (1998). Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. AIDS, 12(4), 433-7. presented at the 1998 Mar 05. doi:10.1097/00002030-199804000-00013